Rajesh Palviya of Axis Sec suggests Linde India, ACME Solar, Ajanta Pharma shares to buy today

+63.3

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

The broader market is under pressure due to geopolitical tensions and rising crude oil, making stock-specific recommendations crucial for investors seeking alpha. Pharma stocks, like Ajanta Pharma, might offer defensive plays during market corrections, while industrial gas (Linde India) and solar (ACME Solar) could be long-term growth bets.

Trading Insight

For pharma, look for companies with strong product pipelines and stable regulatory environments; for industrials/renewables, assess growth prospects independent of short-term market swings. Maintain a bullish bias on these specific recommendations but with tight risk management.

Quick check: LINDEINDIA bullish bias (+7.1% 1d), AJANTPHARM bullish bias (+2.0% 1d).

Key Evidence

•Nifty 50 and Sensex fell around 1.1% on Friday, marking their largest weekly decline in 15 months.
•The market downturn is attributed to the Middle East conflict.
•Brent crude prices remain high, pushing investors away from riskier assets.
•Rajesh Palviya of Axis Securities suggests buying Linde India, ACME Solar, and Ajanta Pharma shares today.
•Risk flag: Continued escalation of Middle East conflict

Affected Stocks

LINDEINDIALinde India Ltd

Positive

Recommended for buying by Axis Securities analyst.

ACME Solar

Positive

Recommended for buying by Axis Securities analyst. (Note: ACME Solar is not directly listed on NSE/BSE as a primary entity, but its parent company ACME Group has various subsidiaries. Assuming the analyst refers to a related listed entity or a general recommendation for the solar sector.)

AJANTPHARMAjanta Pharma Ltd

Positive

Recommended for buying by Axis Securities analyst.

People in this Story

Rajesh Palviya

analyst at Axis Securities

Provided stock recommendations.

Sectors:Chemicals Renewable Energy Pharmaceuticals

AI-powered analysis by

Anadi Algo News